Yixue xinzhi zazhi (Oct 2020)

An analysis of disease burden of bladder cancer in China from 1990 to 2017

  • Hao ZI,
  • Mou PENG,
  • Jiang-Yi WANG,
  • Hai-Liang HU,
  • Lu YANG,
  • Hai-Jun YAO,
  • Zheng CHEN,
  • Jing-Cheng ZHOU,
  • Jia GUO,
  • Xiao-Feng XU,
  • Li-Sha LUO,
  • Xiao-Dong LI,
  • Zhong-Yi SUN,
  • Hong WENG,
  • Tao ZENG,
  • Xian-Tao ZENG

DOI
https://doi.org/10.12173/j.issn.1004-5511.2020.05.01
Journal volume & issue
Vol. 30, no. 5
pp. 328 – 335

Abstract

Read online

Objective To analyze the trend of disease burden of bladder cancer in China from 1990 to 2017.Methods Data were obtained from the results of Global Burden of Disease Study 2017 (GBD 2017). Bladder cancer incidence, mortality, disability-adjusted life year (DALY), years of life lost (YLL), and years lived with disability (YLD) were used to describe the changes of disease burden of bladder cancer in Chinese population between 1990 and 2017. The incidence, mortality, DALY rate, YLL rate, and YLD rate were standardized by the Global Burden of Disease (GBD) global standard population in 2017.Results In 2017, the number of new cases of bladder cancer in China was 73,000 with the standardized incidence rate of 3.89/100,000 and the number of deaths was 30,600 with the standardized mortality rate of 1.75/100,000. Compared to 1990, the number of new cases increased by 164.49% accompanying with the increased incidence rate by 15.09% and the number of deaths increased by 92.45% but accompanying with the decreased standardized mortality rate by 23.58%. Furthermore, male’s incidence and mortality were higher than that of female and showed an upward trend with aging. Compared to 1990, the standardized DALY rate and standardized YLL rate of bladder cancer in China in 2017 decreased by 26.35% and 28.59%, respectively, and the standardized YLD rate increased by 28.83%. From 1990 to 2017, the DALY rate of bladder cancer in China showed a downward trend, but the DALY rate of male was still higher than that of female.Conclusions From 1990 to 2017, the standardized incidence rate of bladder cancer in China continued to rise, and the standardized mortality rate showed a downward trend. Male and elder population was the high-risk population for bladder cancer.

Keywords